Press release
Hereditary Angioedema - Drug Pipeline Landscape, 2022
Hereditary Angioedema
Download Free Sample of Report- https://www.globalinsightservices.com/request-sample/GIS31264
Hereditary Angioedema is an infrequent inherited disease that causes substantial swelling in various body tissues, such as the abdomen or face caused by a low level or improper function of a protein called the C1 inhibitor. There are three types of hereditary angioedema namely type I, II, and III. Hereditary Angioedema is mainly caused by a low level or improper function of a protein called C1 inhibitor. Symptoms are severe abdominal pain and cramping, dehydration, diarrhea and shock, hoarse voice, difficulty swallowing, and difficulty breathing.
Hereditary Angioedema is diagnosed by blood tests that detect decreased levels of complement proteins and erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels.Hereditary Angioedema is treated by medications, such as corticosteroids, antihistamines and epinephrine.
Major pharmaceutical companies are involved in the development of potential drug candidates to improve the treatment of Hereditary Angioedema treatment such as CSL312, Sebetralstat, BMN 331, PHVS719, and others. Key players involved in the development of therapies to treat Hereditary Angioedema are CSL Behring, Kalvista Pharmaceuticals and others. Four drugs are under late-stage Phase III clinical trials and three drugs are in Phase II clinical trials and some other drugs are under Phase I, preclinical and discovery stages of development.
Request For Customization - https://www.globalinsightservices.com/request-customization/GIS31264
In Nov 2022, Ionis Pharmaceuticals Inc presented positive Phase II study of open label extension results of donidalosen. In Oct 2022, KalVista Pharmaceuticals announced positive Phase I data of sebetralstat. In August 2022, Global Biotechnology announed positive top-line Phase III results for garadacimab.
Report Highlights
Global Insight Service's, Hereditary Angioedema - Drug Pipeline Landscape, 2022 report provides an overview of the Hereditary Angioedema pipeline drugs. This report covers detailed insights on Hereditary Angioedema drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Hereditary Angioedema pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
For In-Depth Competitive Analysis, Purchase this Report- https://www.globalinsightservices.com/inquiry-before-buying/GIS31264
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.
Reasons to Buy
Helps to find and recognize significant therapeutics under development. Thorough understanding of pipeline structure and helps in developing corrective measures for pipeline projects.
Effective R&D strategies can be developed with deep knowledge of competitor information, analysis, and insights.
Plan collaborations with various industry partners that have role in some or the other stage of drug development such as contract manufacturing, co-development, contract research organization and commercialization etc.
Helps to create in-licensing and out-licensing opportunities by identifying prospective partners with attractive projects to expand business potential and scope.
With Global Insight Services, you receive:
10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hereditary Angioedema - Drug Pipeline Landscape, 2022 here
News-ID: 2900915 • Views: …
More Releases from Global Insight Services
Clinical Trial Imaging Market Projected to Reach $2.8 Billion by 2034, Driven by …
The Clinical Trial Imaging Market is playing a vital role in shaping the future of drug development and patient care. It integrates cutting-edge imaging modalities such as MRI, CT, PET, and ultrasound into clinical trials, enabling researchers to collect precise data and monitor treatment efficacy with accuracy. These imaging solutions are indispensable for pharmaceutical and biotechnology companies as they help in regulatory compliance and accelerate the path from laboratory research…
Water Taxi Market to Expand from $23 Billion in 2024 to $32.1 Billion by 2034 at …
The Water Taxi Market is becoming a crucial component of modern urban and coastal transportation systems. Designed to provide efficient and scenic travel, water taxis offer commuters and tourists a practical alternative to congested roadways. From small boats to larger ferries, the industry is redefining the way people experience mobility in waterfront cities. With growing concerns about urban congestion, environmental sustainability, and tourism-driven demand, the Water Taxi Market is experiencing…
Radome Market Is Anticipated To Expand From $3.1 Billion In 2024 To $10.9 Billio …
Market Overview
The Radome Market is evolving rapidly as aerospace, defense, telecommunications, and automotive industries increasingly rely on advanced radar systems. Radomes, protective enclosures for radar antennas, are designed to withstand harsh environmental conditions while maintaining electromagnetic signal transparency. Built from sophisticated composite materials, they enhance the durability and performance of radar systems across various applications, from commercial aircraft to naval ships and ground-based communication systems. With global demand for more…
Coenzyme Q10 Market Is Anticipated To Expand From $733.4 Billion In 2024 To $1,8 …
Market Overview
The Coenzyme Q10 Market is experiencing remarkable growth as global health awareness rises and consumers increasingly prioritize wellness, preventive healthcare, and active lifestyles. Coenzyme Q10, commonly known as CoQ10, is a naturally occurring antioxidant that plays a vital role in cellular energy production. Its applications span across dietary supplements, pharmaceuticals, cosmetics, and functional foods, making it a versatile ingredient in today's hea lth-driven society.
Growing interest in cardiovascular health, anti-aging…
More Releases for Hereditary
Hereditary Angioedema Market: An In-Depth Analysis
In 2024, the market for Hereditary Angioedema Market was valued at USD 3.1 billion. It is anticipated to grow to USD 5.9 billion by 2033, with a CAGR of 6.82% over the period 2026-2033.
Hereditary Angioedema Market Overview
The global hereditary angioedema therapeutics market is experiencing significant expansion, driven by increasing awareness, improved diagnostic capabilities, and the introduction of novel treatment options. Advances in genetic research have enabled early and accurate…
Leber Hereditary Optic Neuropathy Treatment Market
Introduction
Leber Hereditary Optic Neuropathy (LHON) is a genetic condition that leads to severe vision loss, primarily affecting young adults. This disorder is caused by mutations in mitochondrial DNA, which impairs the function of retinal ganglion cells. As awareness of LHON has grown, so too has the focus on its treatment options. The LHON treatment market is evolving rapidly, driven by advancements in genetic therapies, pharmaceuticals, and supportive care strategies. This…
Hereditary Hemochromatosis Market - Redefining Care, Inspiring Hope: Hereditary …
Newark, New Castle, USA: The "Hereditary Hemochromatosis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Hereditary Hemochromatosis Market: https://www.growthplusreports.com/report/hereditary-hemochromatosis-market/8793
This latest report researches the industry structure, sales, revenue,…
Hereditary Angioedema Market Research Report 2032
DelveInsight's "Hereditary Angioedema Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the Hereditary Angioedema, historical and forecasted epidemiology as well as the Hereditary Angioedema market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Hereditary Angioedema (HAE) is a rare genetic disorder caused by the deficiency in functional C1 inhibitor (C1INH) that results in recurrent attacks of localized subcutaneous or…
Hereditary Angioedema - Drug Pipeline Landscape, 2022
Hereditary Angioedema is an infrequent inherited disease that causes substantial swelling in various body tissues, such as the abdomen or face caused by a low level or improper function of a protein called the C1 inhibitor. There are three types of hereditary angioedema namely type I, II, and III.
Hereditary Angioedema is mainly caused by a low level or improper function of a protein called the C1 inhibitor.
Read more about Hereditary…
Hereditary Testing Market Size – Forecasts to 2026
The results analyzed by GME showed that the Global Hereditary Testing Market will grow with a CAGR value of 7.1 percent, to hit xx billion USD by 2026. During the forecast timeframe, growth is expected to be driven by growing expenditure on R&D activities and the rising incidence of chronic diseases worldwide. The development may be attributed to the advancement of genetic testing services and the growing demand for personalized…
